Literature DB >> 31004031

The non-erythroid myeloblast count rule in myelodysplastic syndromes: fruitful or futile?

Margot F van Spronsen1, Theresia M Westers1, Birgit I Lissenberg-Witte2, Mariëlle Wondergem1, Gert J Ossenkoppele1, Arjan A van de Loosdrecht3.   

Abstract

Entities:  

Year:  2019        PMID： 31004031      PMCID： PMC6959195          DOI： 10.3324/haematol.2018.212563

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  12 in total

1.  The Di Guglielmo syndrome.

Authors:  W DAMESHEK; M BALDINI
Journal:  Blood       Date:  1958-02       Impact factor: 22.113

2.  Molecular characterization of acute erythroid leukemia (M6-AML) using targeted next-generation sequencing.

Authors:  N Cervera; N Carbuccia; S Garnier; A Guille; J Adélaïde; A Murati; N Vey; M-J Mozziconacci; M Chaffanet; D Birnbaum; V Gelsi-Boyer
Journal:  Leukemia       Date:  2015-07-23       Impact factor: 11.528

3.  Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

Authors:  V Grossmann; U Bacher; C Haferlach; S Schnittger; F Pötzinger; S Weissmann; A Roller; C Eder; A Fasan; M Zenger; M Staller; W Kern; A Kohlmann; T Haferlach
Journal:  Leukemia       Date:  2013-05-07       Impact factor: 11.528

4.  The DiGuglielmo syndrome revisited.

Authors:  W Dameshek
Journal:  Blood       Date:  1969-11       Impact factor: 22.113

5.  Enumerating bone marrow blasts from nonerythroid cellularity improves outcome prediction in myelodysplastic syndromes and permits a better definition of the intermediate risk category of the Revised International Prognostic Scoring System (IPSS-R).

Authors:  Xavier Calvo; Leonor Arenillas; Elisa Luño; Leonor Senent; Montserrat Arnan; Fernando Ramos; Carme Pedro; Mar Tormo; Julia Montoro; María Díez-Campelo; María Laura Blanco; Beatriz Arrizabalaga; Blanca Xicoy; Santiago Bonanad; Andrés Jerez; Meritxell Nomdedeu; Ana Ferrer; Guillermo F Sanz; Lourdes Florensa
Journal:  Am J Hematol       Date:  2017-05-09       Impact factor: 10.047

Review 6.  Erythroleukemia: a need for a new definition.

Authors:  S Park; F Picard; F Dreyfus
Journal:  Leukemia       Date:  2002-08       Impact factor: 11.528

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

Review 8.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Authors:  Daniel A Arber; Attilio Orazi; Robert Hasserjian; Jürgen Thiele; Michael J Borowitz; Michelle M Le Beau; Clara D Bloomfield; Mario Cazzola; James W Vardiman
Journal:  Blood       Date:  2016-04-11       Impact factor: 22.113

9.  Dysplastic erythroid precursors in the myelodysplastic syndromes and the acute myeloid leukemias: Is there biologic significance? (How should blasts be counted?).

Authors:  John M Bennett; Heinz Tuechler; Carlo Aul; Corinna Strupp; Ulrich Germing
Journal:  Leuk Res       Date:  2016-05-12       Impact factor: 3.156

10.  Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes.

Authors:  Leonor Arenillas; Xavier Calvo; Elisa Luño; Leonor Senent; Esther Alonso; Fernando Ramos; María Teresa Ardanaz; Carme Pedro; Mar Tormo; Víctor Marco; Julia Montoro; María Díez-Campelo; Salut Brunet; Beatriz Arrizabalaga; Blanca Xicoy; Rafael Andreu; Santiago Bonanad; Andrés Jerez; Benet Nomdedeu; Ana Ferrer; Guillermo F Sanz; Lourdes Florensa
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.